Oprah Winfrey, the renowned American television host and producer, has recently ignited a significant discussion by sharing her insights on how the use of weight loss medications has altered her perception of individuals who are naturally thin. During a dialogue with Dr. Ania Jastreboff on The Oprah Podcast, the 70-year-old disclosed that her experience with GLP-1 medications, such as Ozempic and Wegovy, has unexpectedly transformed her views regarding thin individuals.

Oprah Winfrey's remark on ‘thin people’

In her commentary on the subject of "thin people," Oprah articulated her realization regarding GLP-1 weight loss drugs, stating, "One of the things that I realized the very first time I took a GLP-1 was that all these years, I thought that thin people—those people—had more willpower." She elaborated, “They consumed healthier foods and were able to maintain their diets for longer periods. They never indulged in a potato chip. Then I came to understand, during my initial experience with the GLP-1, that they are not even preoccupied with it.”

Her statements have rapidly become a focal point of discussion, inciting debates surrounding weight loss and the concept of willpower. Dr. Karan Rajan, a physician known for disseminating scientific knowledge on health and wellness, recently shared a clip of Oprah's remarks on Instagram, providing his own insights. He emphasized the scientific aspects of weight loss, questioning the extent to which willpower influences this complex issue.

Doctor reveals the science behind obesity

Dr. Rajan elucidated, "If you believe that obesity is merely a matter of willpower, you do not fully grasp this intricate metabolic condition." He further explained, "What Oprah is alluding to is termed 'food noise,' and research indicates that 40 to 70% of an individual's susceptibility to weight gain is influenced by genetic factors." He added, "For instance, ghrelin, known as the hunger hormone, increases prior to meals and signals the body to consume food. In certain individuals with obesity, ghrelin levels may remain elevated even after eating, thereby increasing the likelihood of overeating."

He also underscored the significance of leptin, the hormone responsible for signaling satiety. "In numerous individuals with obesity, leptin signaling becomes disrupted, leading to a resistance in the brain that compels them to continue eating." Nevertheless, he stressed that this should not be viewed as an excuse to succumb to one's genetic predispositions. "This merely illustrates that weight loss may present greater difficulties for certain individuals," he remarked.

'Obesity rates aren't rising globally because of a willpower issue'

Dr. Rajan elaborated further, stating, "In a carefully selected cohort of patients, medications such as GLP-1 agonists may serve as beneficial supplements to lifestyle modifications, aiding in the adjustment of specific biological hunger signals and enhancing metabolic conditions."

He concluded by asserting, "The global increase in obesity rates cannot be attributed solely to a lack of willpower. It is rising because we are focusing on the symptoms rather than the underlying system. It is far simpler to assign blame to individuals than to address the complexities of food policy or the biological factors that contribute to this issue."

Read Also: A woman who lost 36 kg shares a calorie deficit diet plan high in protein and fiber to promote satiety during weight loss

Get the latest Bollywood entertainment news, trending celebrity news, latest celebrity news, new movie reviews, latest entertainment news, latest Bollywood news, and Bollywood celebrity fashion & style updates!